Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


08.01.2018

1 Am J Epidemiol
1 Ann Intern Med
2 Antimicrob Agents Chemother
1 BMJ
26 Int J Tuberc Lung Dis
1 J Antimicrob Chemother
2 J Clin Microbiol
1 Lancet Infect Dis
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Epidemiol

  1. STEIN CM, Zalwango S, Malone LL, Thiel B, et al
    Resistance and Susceptibility to Mycobacterium Tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda.
    Am J Epidemiol. 2018 Jan 3. pii: 4786120. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Intern Med


  2. Correction: Tailoring Treatment of Latent Tuberculosis to the Needs of Patients and Families.
    Ann Intern Med. 2018;168:84.
    PubMed     Text format    


    Antimicrob Agents Chemother

  3. VILCHEZE C, Kim J, Jacobs WR Jr
    Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and rifampicin in mice.
    Antimicrob Agents Chemother. 2018 Jan 3. pii: AAC.02165.
    PubMed     Text format     Abstract available

  4. MOREIRA W, Santhanakrishnan S, Ngan GJY, Low CB, et al
    Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome.
    Antimicrob Agents Chemother. 2017;61.
    PubMed     Text format     Abstract available


    BMJ

  5. COUSINS S
    Progress towards TB reduction targets is faltering, report finds.
    BMJ. 2017;359:j4758.
    PubMed     Text format    


    Int J Tuberc Lung Dis

  6. GUGLIELMETTI L, Veziris N, Aubry A, Brossier F, et al
    Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Int J Tuberc Lung Dis. 2018;22:54-59.
    PubMed     Text format     Abstract available

  7. LEE B, Oh HJ, Chon BS
    Estimating the impact of a television campaign on tuberculosis knowledge and intention to test for TB in South Korea.
    Int J Tuberc Lung Dis. 2018;22:60-64.
    PubMed     Text format     Abstract available

  8. SHIMAZAKI T, Taniguchi T, Saludar NRD, Gustilo LM, et al
    Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines.
    Int J Tuberc Lung Dis. 2018;22:65-72.
    PubMed     Text format     Abstract available

  9. WONG J, Lowenthal P, Flood J, Watt J, et al
    Increased tuberculosis risk among immigrants arriving in California with abnormal domestic chest radiographs.
    Int J Tuberc Lung Dis. 2018;22:73-79.
    PubMed     Text format     Abstract available

  10. BYRNE AL, Marais BJ, Mitnick CD, Garden FL, et al
    Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.
    Int J Tuberc Lung Dis. 2018;22:86-92.
    PubMed     Text format     Abstract available

  11. EI PW, Aung WW, Nyunt WW, Swe TL, et al
    Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Int J Tuberc Lung Dis. 2018;22:47-53.
    PubMed     Text format     Abstract available

  12. LOVEDAY M, Sunkari B, Master I, Daftary A, et al
    Household context and psychosocial impact of childhood multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2018;22:40-46.
    PubMed     Text format     Abstract available

  13. PAYEN MC, Muylle I, Vandenberg O, Mathys V, et al
    Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Text format     Abstract available

  14. COURT R, Wiesner L, Stewart A, de Vries N, et al
    Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:30-33.
    PubMed     Text format     Abstract available

  15. LEE PH, Fu H, Lee MR, Magee M, et al
    Tuberculosis and diabetes in low and moderate tuberculosis incidence countries.
    Int J Tuberc Lung Dis. 2018;22:7-16.
    PubMed     Text format     Abstract available

  16. JACKSON C, Cohen T, Rangaka MX, Abubakar I, et al
    Eliminating tuberculosis in low-burden countries.
    Int J Tuberc Lung Dis. 2018;22:3.
    PubMed     Text format    

  17. ALFFENAAR JWC, Peloquin CA, Migliori GB
    Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
    Int J Tuberc Lung Dis. 2018;22:2.
    PubMed     Text format    

  18. PINTO PFPS, Neto FC, de Almeida Ribeiro MCS
    Tuberculosis among South American immigrants in Sao Paulo municipality: an analysis in space and time.
    Int J Tuberc Lung Dis. 2018;22:80-85.
    PubMed     Text format     Abstract available

  19. COX V, Furin J
    World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?
    Int J Tuberc Lung Dis. 2017;21:1211-1213.
    PubMed     Text format     Abstract available

  20. DELORY T, Ferrand H, Grall N, Casalino E, et al
    Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
    Int J Tuberc Lung Dis. 2017;21:1272-1279.
    PubMed     Text format     Abstract available

  21. ZELLWEGER JP
    Depression and risk of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1314.
    PubMed     Text format    

  22. YU ZG, Wang BZ, Li J, Ding ZL, et al
    Association between interleukin-17 genetic polymorphisms and tuberculosis susceptibility: an updated meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1307-1313.
    PubMed     Text format     Abstract available

  23. SHU E, Sobieszczyk ME, Sal Y Rosas VG, Segura P, et al
    Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:1288-1293.
    PubMed     Text format     Abstract available

  24. MAVE V, Meshram S, Lokhande R, Kadam D, et al
    Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.
    Int J Tuberc Lung Dis. 2017;21:1280-1287.
    PubMed     Text format     Abstract available

  25. DALE K, Tay E, Trauer JM, Trevan P, et al
    Gender differences in tuberculosis diagnosis, treatment and outcomes in Victoria, Australia, 2002-2015.
    Int J Tuberc Lung Dis. 2017;21:1264-1271.
    PubMed     Text format     Abstract available

  26. KUMWENDA M, Nyang'wa BT, Chikuse B, Biseck T, et al
    The second sputum sample complicates tuberculosis diagnosis for women: a qualitative study from Malawi.
    Int J Tuberc Lung Dis. 2017;21:1258-1263.
    PubMed     Text format     Abstract available

  27. NAGU T, Ray R, Munseri P, Moshiro C, et al
    Tuberculosis among the elderly in Tanzania: disease presentation and initial response to treatment.
    Int J Tuberc Lung Dis. 2017;21:1251-1257.
    PubMed     Text format     Abstract available

  28. MOH R, Badje A, N'takpe JB, Kouame GM, et al
    Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Int J Tuberc Lung Dis. 2017;21:1237-1244.
    PubMed     Text format     Abstract available

  29. SURETTE MA, Beattie P, Nyirenda T, Olesen OF, et al
    Tackling tuberculosis in sub-Saharan Africa: EDCTP achievements and the road ahead.
    Int J Tuberc Lung Dis. 2017;21:1220-1229.
    PubMed     Text format     Abstract available

  30. HUANGFU P, Pearson F, Ugarte-Gil C, Critchley J, et al
    Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.
    Int J Tuberc Lung Dis. 2017;21:1214-1219.
    PubMed     Text format     Abstract available

  31. ALLWOOD BW, van Zyl-Smit R
    Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web.
    Int J Tuberc Lung Dis. 2017;21:1317-1318.
    PubMed     Text format    


    J Antimicrob Chemother

  32. NAIDOO A, Chirehwa M, McIlleron H, Naidoo K, et al
    Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.
    J Antimicrob Chemother. 2017;72:1441-1449.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  33. THERON G, Venter R, Smith L, Esmail A, et al
    False positive Xpert MTB/RIF results in re-tested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes.
    J Clin Microbiol. 2018 Jan 5. pii: JCM.01696-17. doi: 10.1128/JCM.01696.
    PubMed     Text format     Abstract available

  34. LINGER Y, Knickerbocker C, Sipes D, Golova J, et al
    Genotyping Multi-Drug Resistant M. tuberculosis from Primary Sputum and Decontaminated Sediment with an Integrated Microfluidic Amplification Microarray.
    J Clin Microbiol. 2018 Jan 5. pii: JCM.01652-17. doi: 10.1128/JCM.01652.
    PubMed     Text format     Abstract available


    Lancet Infect Dis

  35. HOLT E
    Tuberculosis on the political agenda.
    Lancet Infect Dis. 2018;18:30.
    PubMed     Text format    


    PLoS One

  36. MACIEL EMGS, Amancio JS, Castro DB, Braga JU, et al
    Social determinants of pulmonary tuberculosis treatment non-adherence in Rio de Janeiro, Brazil.
    PLoS One. 2018;13:e0190578.
    PubMed     Text format     Abstract available

  37. FELEKE BE, Alene GD, Feleke TE, Motebaynore Y, et al
    Clinical response of tuberculosis patients, a prospective cohort study.
    PLoS One. 2018;13:e0190207.
    PubMed     Text format     Abstract available

  38. LI J, Yip BHK, Leung C, Chung W, et al
    Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    PLoS One. 2018;13:e0189531.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: